<DOC>
	<DOCNO>NCT02752724</DOCNO>
	<brief_summary>The purpose prospective randomize clinical trial determine patient receive ketamine part general anesthesia electroconvulsive therapy ( ECT ) rather standard care improvement symptom depression course ECT treatment . The investigator hypothesize utilization ketamine induction general anesthesia ECT treatment improve symptom depression well , standard care . This study ONLY open patient eligible receive healthcare service Department Veterans Affairs VA Puget Sound , mean service active military , naval air service separation condition dishonorable . Qualifications VA health care benefit find va.gov .</brief_summary>
	<brief_title>Ketamine Anesthesia Improvement Depression ECT</brief_title>
	<detailed_description>The purpose prospective randomize clinical trial determine patient receive ketamine part general anesthesia electroconvulsive therapy ( ECT ) rather standard care improvement symptom depression course ECT treatment . The investigator hypothesize utilization ketamine induction general anesthesia ECT treatment improve symptom depression well , standard care . For induction general anesthesia ECT , patient receive either 1mg/kg methohexital ( standard arm ) 1.0 mg/kg IV ketamine ( experimental arm ) intravenously ( IV ) duration ECT index course 2-3 week . The primary outcome trial change symptom depression assess standard questionnaire : Patient Health Questionnaire 9 ( PHQ9 ) Hamilton Depression Rating Scale ( HDRS ) score change baseline final ECT administration . Secondary outcome change cognitive status assess Montreal Cognitive Assessment ( MoCA ) scale , quality seizure , change regional cerebral oximetry seizure , change serum metabolite ( include kynurenine , D/L-serine glutamate intermediate ) treatment , , need ECT course ( relapse ) within 1 year initial course . Up 150 veteran diagnosis major depressive disorder bipolar 1 2 old 18 year age undergoing ECT randomize blind intervention . Operative ECT clinician blind ; clinician evaluate patient blind . Exclusion criterion study include uncontrolled hypertension , blood pressure &gt; 180/90 mmHg pre-anesthesia clinic visit , renal failure , neurologic disorder ( e.g . epilepsy , space occupy lesion , traumatic brain injury past 6 month ) , myocardial infarction past 6 month , know allergy adverse reaction ketamine , American Society Anesthesiology Physical Class great 3 , concomitant psychosis , schizophrenia current abuse alcohol illicit substance pregnancy . The long term objective trial systematically characterize ketamine 's effect depression outcomes utilizing validated scoring tool , safety profile throughout ECT index course , ketamine 's effect seizure quality change novel translational endpoint well understand mechanisms action ketamine potential role treatment psychiatric disorder .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Methohexital</mesh_term>
	<criteria>outpatient inpatient Puget Sound VA diagnosis major depressive disorder bipolar 1 2 age 18 undergoing index course ECT uncontrolled hypertension ( blood pressure &gt; 180/90 mmHg preanesthesia clinic visit ) renal failure neurologic disorder ( e.g . epilepsy , space occupy lesion , traumatic brain injury past 6 month ) myocardial infarction past 6 month know allergy adverse reaction ketamine American Society Anesthesiology Physical Class great 3 concomitant psychosis schizophrenia current abuse alcohol illicit substance pregnancy ( trimester )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>major depressive disorder</keyword>
	<keyword>electroconvulsive therapy</keyword>
	<keyword>metabolomics</keyword>
	<keyword>treatment resistant depression</keyword>
	<keyword>anesthesiology</keyword>
	<keyword>ketamine</keyword>
	<keyword>prospective randomize clinical trial</keyword>
</DOC>